IF this ends up working it sounds like a great painkiller. Still very early days. Currently a phase 2a study with 30 patients. Read out approx Sept 2023.
If successful I assume it would move to phase 3 (or larger phase 2) after negotiations with FDA trial design approvals etc. You're prob looking at phase 3 read out in 2028 and beyond if all goes well....
And this is pain only. It's a band aid. Will not be joint modifying or restorative in any way and in fact may encourage people to use their joints more which may lead to further destruction?
You still need to break that inflammatory cycle.
That's why zilosol is the magic juice.
Competition???, page-3
-
- There are more pages in this discussion • 66 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
-0.005(2.38%) |
Mkt cap ! $71.73M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 21.0¢ | 20.0¢ | $152.8K | 744.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 78174 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 84426 | 5 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |